| A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain J Raskin, YL Pritchett, F Wang, DN D'Souza, AL Waninger, S Iyengar, ... Pain Medicine 6 (5), 346-356, 2005 | 733 | 2005 |
| A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain JF Wernicke, YL Pritchett, DN D’souza, A Waninger, P Tran, S Iyengar, ... Neurology 67 (8), 1411-1420, 2006 | 646 | 2006 |
| Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial J Raskin, CG Wiltse, A Siegal, J Sheikh, J Xu, JJ Dinkel, BT Rotz, ... American Journal of Psychiatry 164 (6), 900-909, 2007 | 467 | 2007 |
| On the path to 2025: understanding the Alzheimer’s disease continuum PS Aisen, J Cummings, CR Jack, JC Morris, R Sperling, L Frölich, ... Alzheimer's research & therapy 9, 1-10, 2017 | 450 | 2017 |
| Drug development in Alzheimer’s disease: the path to 2025 J Cummings, PS Aisen, B DuBois, L Frölich, CR Jack, RW Jones, ... Alzheimer's research & therapy 8, 1-12, 2016 | 428 | 2016 |
| Anorexia nervosa, bulimia, and pregnancy DE Stewart, J Raskin, PE Garfinkel, OL MacDonald, GE Robinson American Journal of Obstetrics and Gynecology 157 (5), 1194-1198, 1987 | 211 | 1987 |
| Neurobiology of Alzheimer’s disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions J Raskin, J Cummings, J Hardy, K Schuh, R A Dean Current Alzheimer Research 12 (8), 712-722, 2015 | 204 | 2015 |
| Psychiatric assessment of patients with “20th-century disease”(“total allergy syndrome”) DE Stewart, J Raskin CMAJ: Canadian Medical Association Journal 133 (10), 1001, 1985 | 198 | 1985 |
| Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects SH Kennedy, SM McCann, M Masellis, RS McIntyre, J Raskin, G McKay, ... Journal of Clinical Psychiatry 63 (3), 181-186, 2002 | 184 | 2002 |
| Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible‐dose, progressive‐titration, placebo‐controlled trial M Rynn, J Russell, J Erickson, MJ Detke, S Ball, J Dinkel, K Rickels, ... Depression and Anxiety 25 (3), 182-189, 2008 | 180 | 2008 |
| Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain J Raskin, TR Smith, K Wong, YL Pritchett, DN D'souza, S Iyengar, ... Journal of palliative medicine 9 (1), 29-40, 2006 | 169 | 2006 |
| An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies J Wernicke, A Lledo, J Raskin, DK Kajdasz, F Wang Drug safety 30, 437-455, 2007 | 166 | 2007 |
| Duloxetine in the long-term treatment of major depressive disorder J Raskin, DJ Goldstein, CH Mallinckrodt, MB Ferguson Journal of Clinical Psychiatry 64 (10), 1237-1244, 2003 | 161 | 2003 |
| microRNA therapies in cancer SI Rothschild Molecular and cellular therapies 2, 1-8, 2014 | 149 | 2014 |
| A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder DGS Perahia, YL Pritchett, DK Kajdasz, M Bauer, R Jain, JM Russell, ... Journal of psychiatric research 42 (1), 22-34, 2008 | 127 | 2008 |
| Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect? DGS Perahia, YL Pritchett, D Desaiah, J Raskin International clinical psychopharmacology 21 (6), 311-317, 2006 | 126 | 2006 |
| Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study J Raskin, F Wang, YL Pritchett, DJ Goldstein Pain Medicine 7 (5), 373-385, 2006 | 116 | 2006 |
| Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a … S Brecht, C Courtecuisse, C Debieuvre, J Croenlein, D Desaiah, J Raskin, ... Journal of Clinical Psychiatry 68 (11), 1707-1716, 2007 | 110 | 2007 |
| Interim results of a prospective, randomized, open-label, phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study) JL Brandes, S Klise, JH Krege, M Case, R Khanna, R Vasudeva, J Raskin, ... Cephalalgia 39 (11), 1343-1357, 2019 | 99 | 2019 |
| Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine J Greist, RK McNamara, CH Mallinckrodt, JN Rayamajhi, J Raskin Clinical therapeutics 26 (9), 1446-1455, 2004 | 89 | 2004 |
